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ABSTRACT
Objectives: To determine the variation in charges for
10 common blood tests across California hospitals in
2011, and to analyse the hospital and market-level
factors that may explain any observed variation.
Design, setting and participants: We conducted a
cross-sectional analysis of the degree of charge
variation between hospitals for 10 common blood tests
using charge data reported by all non-federal California
hospitals to the California Office of Statewide Health
Planning and Development in 2011.
Outcome measures: Charges for 10 common blood
tests at California hospitals during 2011.
Results: We found that charges for blood tests varied
significantly between California hospitals. For example,
charges for a lipid panel ranged from US$10 to US
$10 169, a thousand-fold difference. Although
government hospitals and teaching hospitals were found
to charge significantly less than their counterparts for
many blood tests, few other hospital characteristics and
no market-level predictors significantly predicted charges
for blood tests. Our models explained, at most, 21% of
the variation between hospitals in charges for the blood
test in question.
Conclusions: These findings demonstrate the
seemingly arbitrary nature of the charge setting process,
making it difficult for patients to act as true consumers in
this era of ‘consumer-directed healthcare.’
BACKGROUND
In our notoriously opaque healthcare system,
pricing information in healthcare is rarely
available to patients in advance of their
care.1 Numerous legal and institutional bar-
riers, such as contractual gag clauses by
insurers, and limited availability of reported
charges in a consumer-friendly format, have
limited patient access to the true costs of
their care.2 As former Secretary of Health
and Human Services, Mike Leavitt, said,
“Americans know the price of almost every-
thing they pay for, except for one of the
most important things they pay for—their
healthcare.”3
As patients have little control over their
clinical presentation, one of the primary ways
to control their healthcare costs is in the
choice of provider. The research has shown
large between-hospital variations in broad
price indices,4 5 as well as charges for the
average inpatient stay6 and charges for
common surgical procedures,7 indicating
possible room for consumer discrimination.
However, no studies, to our knowledge, have
examined variation in charges for line-item
outpatient procedures, such as blood tests,
which are theoretically identical across provi-
ders. These procedures should have no vari-
ability by patient characteristics or clinical
presentation, and thus provide an ideal
element on which to evaluate the true
between-hospital variation in charges and the
possible explanations for that variation.
We sought to determine the across-hospital
variation in charges for 10 common blood
tests performed at California hospitals in
2011, as well as the hospital and market-level
factors that could explain such variation.
Using these common, simple and standard
tests as a vehicle, institutional differences in
charges could be isolated by eliminating pos-
sible patient-speciﬁc variation. Further, as a
common element of almost any hospital visit,
these blood tests provide a relevant and
Strengths and limitations of this study
▪ Uses line-item charges for 10 common blood
tests, which should have no variability by patient
characteristics or clinical presentation, to isolate
institutional differences in charges.
▪ Links reported charge data to hospital and
market characteristics, allowing for analysis of
the predictive power of different institutional
factors on between-hospital charge variation.
▪ Limitations include using self-reported charge
data from hospitals, lack of generalisability
beyond California, potential selection bias and
inability to conduct the same analysis on prices
paid rather than charges.
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meaningful example of the variation patients may face
in the bills from their healthcare use.
METHODS
Study design and data sources
We conducted a cross-sectional study of hospital charges
for 10 common outpatient blood tests performed at
California hospitals in 2011. Since 2006, all non-federal
hospitals in California have been required by law to
annually submit their average charges for 25 common
outpatient procedures to the California Ofﬁce of
Statewide Health Planning and Development
(OSHPD).8 While the choice of which 25 procedures to
report are at the discretion of each hospital, OSHPD
provides a sample list of common procedures to aid in
the reporting process. That suggested form includes 10
common blood tests; basic metabolic panel, complete
blood cell count with differential white cell count, com-
prehensive metabolic panel, lipid panel, complete blood
cell count (automated), thyroid-stimulating hormone
assay, creatine kinase assay, troponin assay, prothrombin
time and thromboplastin time (partial). By 2007, over
85% of hospitals used this form. Thus, we selected these
10 commonly reported blood tests for our analysis. The
10 blood tests, their current procedural terminology
(CPT) codes, and their frequency of reporting by hospi-
tals in our sample are reported in online supplementary
table S1.
Hospital characteristics were captured by linking
OSHPD’s hospital utilisation ﬁles for 2011 with the
charge data using each hospital’s OSHPD ID. We also
used the 2009 Area Health Resources File,9 the most
currently available year, to obtain county-level area
percent of uninsurance and poverty, and the 2011
Impact Files from the Centers for Medicare and
Medicaid Services (CMS),10 to obtain hospital wage and
case-mix indices.
Our study was exempted from review by the
Committee on Human Research at the University of
California, San Francisco, as it did not involve any
human subjects.
Sample selection
We only analysed charges from general acute care,
medical/surgical hospitals. We also excluded any hospi-
tals from the individual test analyses that did not report
charges for that speciﬁc blood test to OSHPD as one of
their 25 common outpatient procedures. Of the 307 hos-
pitals reporting charges to OSHPD, between 166 and
189 hospitals reported charges for each individual blood
test.
Outcome
Our outcome of interest was the average charge at each
hospital for the blood test of interest, which represents
the total dollar amount billed by the hospital to the
patient or to their insurance provider. The charges
reﬂect the hospital’s full rates before pre-payments or
contractual adjustments.
Covariates
To determine which characteristics explain the observed
variation in charges for common blood tests, we exam-
ined hospital and market-level factors that have been
shown to have relationships with broad hospital-price
indices in the previous literature.4 11 12 Hospital-level
factors included ownership (not-for-proﬁt, for-proﬁt,
government), urban/rural location, teaching status,
patient payer mix (proportion Medicare, Medicaid),
capacity (number of licensed beds), case-mix index and
wage index. Market-level factors included percent unin-
sured in the county, percent below the poverty line in
the county as well as the system-wide
Herﬁndahl-Hirschman Index (HHI).
The HHI is deﬁned as the sum of the squares of the
market shares, and is a widely used economic measure
of market concentration. HHI can range from 0 to
10 000 (using whole percentages). A monopoly market
has an HHI of 10 000 and a market that has a large
number of ﬁrms has HHI that approaches 0. We calcu-
lated a hospital’s share of patients in its market directly
from the OSHPD hospital utilisation data. Our HHI cal-
culation accounts for membership in a hospital system,
which has been shown to inﬂuence hospital charges.4 To
parameterise HHI in our regression, we divided it into
terciles.
Statistical analyses
We ﬁrst conducted a descriptive analysis of average
charges for each blood test, including minima and
maxima, 5th and 95th percentile of charges, IQR and
coefﬁcient of variation, to examine the variation across
California hospitals. The coefﬁcient of variation is deter-
mined by dividing the SD of a distribution by the mean
to create a normalised measure of variation that can be
used to compare groups with different means.
We then used a linear regression model to determine
if hospital or market-level characteristics described above
inﬂuenced hospital charges for these common blood
tests. We also determined the R2 value for each model,
which expresses how much of the variation in charges is
explained by the hospital and market characteristics.
RESULTS
We analysed charges for between 166 and 189 hospitals,
depending on the blood test, as not all blood tests were
included in each hospital’s 25 reported outpatient proce-
dures (table 1). The majority of hospitals were
not-for-proﬁt, urban, non-teaching hospitals. Their patient
populations were on average 25% Medicaid and 41%
Medicare, and they averaged 269 beds. Most markets had
medium levels of competition (HHI: 1500–2500).
Hospitals’ counties averaged 19% uninsurance rates and
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Table 1 Hospital and market characteristics in study sample
Basic
metabolic
panel
Complete CBC
with/automated
differential WCC
Comprehensive
metabolic panel
Lipid
panel
Complete
CBC
automated
Assay
thyroid-stimulating
hormone
Assay of
ck (cpk)
Assay of
troponin
quant
Prothrombin
Time
Thrombo-plastin
time, partial
Hospital-level characteristics
N (%)
Total number
of hospitals
reporting
blood test
189 186 183 178 171 170 166 169 180 167
Ownership
Government 24 (13) 21 (11) 24 (13) 25 (14) 20 (12) 20 (12) 23 (14) 22 (13) 21 (12) 20 (12)
Non-profit 118 (62) 117 (63) 113 (62) 108 (61) 112 (65) 104 (61) 108 (65) 102 (60) 112 (62) 100 (60)
For-profit 47 (25) 48 (26) 46 (25) 45 (25) 39 (23) 46 (27) 35 (21) 45 (27) 47 (26) 47 (28)
Location
Urban 169 (89) 167 (90) 164 (90) 158 (89) 155 (91) 151 (89) 148 (89) 149 (88) 161 (89) 148 (89)
Rural 20 (11) 19 (10) 19 (10) 20 (11) 16 (9) 19 (11) 18 (11) 20 (12) 19 (11) 19 (11)
Teaching status
Yes 14 (7) 14 (8) 13 (7) 13 (7) 15 (9) 13 (8) 13 (8) 12 (7) 15 (8) 13 (8)
No 175 (93) 172 (92) 170 (93) 165 (93) 156 (91) 157 (92) 153 (92) 157 (93) 165 (92) 154 (92)
Mean (SD)
Case mix (tertiles)
Low 1.27 (0.13) 1.27 (0.13) 1.26 (0.13) 1.27 (0.14) 1.28 (0.12) 1.27 (0.14) 1.25 (0.14) 1.26 (0.14) 1.26 (0.14) 1.26 (0.14)
Medium 1.55 (0.06) 1.55 (0.06) 1.55 (0.06) 1.55 (0.06) 1.56 (0.06) 1.55 (0.06) 1.54 (0.06) 1.55 (0.05) 1.55 (0.05) 1.55 (0.06)
High 1.81 (0.19) 1.81 (0.19) 1.80 (0.18) 1.81 (0.19) 1.80 (0.17) 1.81 (0.20) 1.80 (0.17) 1.80 (0.20) 1.81 (0.19) 1.81 (0.20)
Licensed
beds
269 (174) 271 (175) 269 (172) 266 (175) 276 (180) 268 (177) 266 (176) 266 (177) 269 (177) 269 (177)
% Medicare 42% (12) 41% (13) 41% (13) 42% (13) 41% (13) 41% (12) 41% (12) 41% (12) 41% (12) 41% (13)
% Medicaid 25% (15) 25% (16) 25% (16) 25% (15) 25% (16) 25% (15) 25% (15) 25% (15) 25% (15) 25% (16)
Market-level characteristics
N (%)
Herfindal-Hirschman Index
Low 63 (33) 64 (34) 64 (35) 60 (34) 57 (33) 58 (34) 60 (36) 59 (35) 60 (33) 56 (34)
Medium 82 (43) 60 (32) 58 (32) 75 (42) 73 (43) 72 (42) 66 (40) 54 (32) 77 (43) 69 (41)
High 44 (23) 62 (33) 61 (33) 43 (24) 41 (24) 40 (24) 40 (24) 56 (33) 43 (24) 43 (26)
Mean (SD)
Wage Index 1.29 (0.16) 1.29 (0.16) 1.29 (0.16) 1.30 (0.16) 1.30 (0.16) 1.30 (0.16) 1.29 (0.16) 1.30 (0.16) 1.30 (0.16) 1.30 (0.16)
% Without
insurance
19% (4) 19% (4) 19% (4) 19% (4) 19% (4) 19% (4) 19% (4) 19% (4) 19% (4) 19% (4)
% Below
poverty line
13% (4) 13% (4) 13% (4) 13% (4) 13% (4) 13% (3) 14% (4) 13% (4) 13% (4) 13% (4)
CBC, complete blood cell count; ck, creatine kinase; WCC, white cell count.
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13% of the population living below the federal poverty
line.
We found signiﬁcant variation in charges for 10
common outpatient blood tests performed at California
hospitals (ﬁgure 1: tabular results in additional ﬁle 1).
For example, hospitals charged a median of US$214 for
a basic metabolic panel, but the charges ranged from
US$35 to US$7303. A lipid panel generated a median
charge of US$220 at California hospitals, but the
maximum charge of US$10 169 was over a thousand
times the minimum charge of US$10.
To exclude extreme cases, we further examined vari-
ation in charges from the 5th to 95th percentile, ﬁnding
that a comprehensive metabolic panel had the largest
range at US$869 (US$79–US$948), and charges for an
automated complete blood count had the smallest range
at US$241 (US$37–US$278). When examining IQR, a
more conservative measure of variation, we found that
IQRs varied from US$83 for an automated complete
blood count to US$354 for a comprehensive metabolic
panel.
Finally, the coefﬁcient of variation for each blood test
ranged from 67% for assays of creatine kinase to 422%
for prothrombin time. Eight of the 10 blood test charges
had coefﬁcients of variation greater than 200%.
We found that multiple hospital-level factors were asso-
ciated with individual blood test charges (table 2). For 7
of the 10 blood tests, receiving the test at a teaching hos-
pital was associated with a signiﬁcantly lower charge. For
instance, the charge for a troponin assay at a teaching
hospital was 65% lower than at a non-teaching hospital
(95% CI −25% to −104%). Five of 10 blood tests had
lower charges at government hospitals than non-proﬁts,
while 2 of 10 tests had signiﬁcantly higher charges at for-
proﬁt hospitals than non-proﬁts. For lipid panels, each
percentage increase in the share of Medicaid patients
was associated with a 0.95% increase (95% CI 0.09% to
1.80%), meaning that if a hospital had a 10% higher
share of Medicaid patients in their payer mix, the
charges in that hospital for the lipid panel would be
9.5% higher. However, for each blood test, only two or
fewer hospital characteristics and no market predictors
showed any signiﬁcant association with charges. At most,
our models predicted 21% of the variation in charges
between hospitals.
DISCUSSION
Our ﬁndings demonstrate the wide variability in charges
for 10 common blood tests performed at California hos-
pitals in 2011, as well as the hospital-level factors that
explain some of that variation. We found that a patient
could be charged as little as US$10 or as much as US
$10 169 for a lipid panel, depending only on which hos-
pital they visited. Eight of the 10 blood tests had coefﬁ-
cients of variation greater than 200%. For comparison,
prices for consumer electronic goods have an average
coefﬁcient of variation of 12.5%.13
The between-hospital variation we observed in some
of these blood tests was partially explained by a few
hospital-level factors including ownership, teaching
status and in the case of lipid panels, the proportion of
a hospital’s patients covered by Medicaid. However, it is
notable how few characteristics were signiﬁcant predic-
tors of the charges patients faced. For instance, our
results indicate that a hospital’s case mix and labour
costs (wage index) do not affect charges for these
common procedures. Market level characteristics,
including competitiveness of the hospital market,
percent uninsured in the hospital’s county and county
poverty rate, also showed no signiﬁcant effects on
charges for any of the 10 blood tests. The signiﬁcant
Figure 1 Variation in charges
for 10 common blood tests in
California (CBC, complete blood
cell count; ck, creatine kinase;
WCC, white cell count). Central
lines represent median charges,
boxes represent the IQR of
charges, and whiskers show the
5th and 95th centile of charges
for each of the 10 common blood
tests.
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Table 2 Regression of hospital charges on hospital and market characteristics for 10 common blood tests performed in California hospitals
Multiplicative increase for each unit change in predictor
Basic
metabolic
panel
Complete
CBC with/
automated
differential
WCC
Compre-hensive
metabolic panel
Lipid
panel
Complete
CBC
automated
Assay
thyroid-stimulating
hormone
Assay
of ck
(cpk)
Assay of
troponin
quant
Pro-thrombin
time
Thrombo-plastin
time, partial
Hospital-level characteristics
Ownership
Government −0.58* −0.37* −0.45* −0.26** −0.34* −0.33** −0.18 −0.28** −0.38** −0.46*
Non-profit ref ref ref ref ref ref ref ref ref ref
For-profit 0.41* 0.17 0.50* 0.17 0.07 −0.10 0.17 0.15 0.05 0.21
Teaching
hospital
−0.38** −0.60* −0.45** −0.35** −0.64* −0.44* −0.67* −0.65* −0.67* −0.57*
Rural MSA 0.25 0.17 0.11 0.11 0.14 −0.01 0.02 0.14 0.24 0.23
Number of
licensed beds
0.00 0.00 0.00 0.00 0.00** 0.00 0.00** 0.00 0.00 0.00
Patient mix
Proportion
medicare
0.12 0.21 0.25 0.33 0.28 −0.21 0.64 −0.06 0.05 0.12
Proportion
medicaid
0.94** 0.81 0.87 0.95* 0.77 0.80 0.35 0.58 1.20** 0.74
Case mix (severity)
Quartile 2 0.31** 0.32** 0.31** 0.29 0.15 0.32** 0.07 0.24 0.34 0.21
Quartile 3 0.16 0.15 0.16 0.26 0.06 0.30** 0.10 0.26 0.33 0.26
Wage Index 0.82 0.65 0.53 −0.03 0.57 0.18 0.34 0.23 0.62 −0.12
Market-level characteristics
Proportion
with out health
insurance
2.34 1.03 3.24 −0.72 −2.20 −2.87 −2.04 −1.38 2.11 −0.58
Proportion in
poverty
1.36 0.91 −0.78 −0.52 3.49 0.98 2.95 0.06 −0.35 0.04
Herfindal-Hirschman Index
Quartile 2 0.00 −0.15 −0.12 0.01 −0.05 0.00 −0.21 −0.03 −0.18 0.03
Quartile 3 −0.24 0.03 0.02 0.08 −0.20 0.15 −0.28** −0.04 −0.33 −0.02
Variation explained by the model
R2 20% 15% 21% 12% 13% 16% 13% 14% 15% 14%
*p<0.05; **p<0.10.
CBC, complete blood cell count; ck, creatine kinase; WCC, white cell count.
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variation left unexplained in our models could be due
to our inability to capture all relevant factors that could
affect charge setting for these tests, or to pure noise.
Though we attempted to investigate a range of hospital
and market characteristics from previous literature on
charge variation in aggregate inpatient indices and surgi-
cal procedures,4 7 11 14 there are numerous factors that
could explain hospital variation in charges for blood tests
that we were unable to include in our regression. For
example, many hospitals may choose to invest in higher
quality facilities, supplementary services and social services
than others. The costs of these differences, while of value
to patients, are not easy to measure and may not be cap-
tured by variables in our regression, such as wage index.
However, they likely do trickle down into charges for all
basic services, including blood tests. Additional neighbour-
hood factors in the hospital’s catchment area such as edu-
cation, home prices, age distribution and race/ethnicity
breakdown may inﬂuence charges, but were not included
in our regression due to absence from previous literature
on potential explanatory factors in charge setting,4 7 11 14
on which we based our decisions of which variables to
include. Thus, it is possible that some portion of the vari-
ation left unexplained by our model could be explained
by additional characteristics of the hospital or market not
included in our regression.
However, given past literature suggesting that system-
wide factors incentivise nearly random charge setting, we
believe that the majority of the variation in blood test
charges between hospitals that remains unexplained by
our model is not based on cost or observable market
characteristics. For instance, previous literature shows that
prospective payments from purchasers are often set inde-
pendently of costs or value, eliminating the typical free-
market constraints by which variation in charge and price
would be limited.15 Rather, as payments by private insurers
are often negotiated based on charges, hospitals use pro-
prietary formulas to raise their charges in order to secure
sufﬁcient funding from third party payers to cover overall
costs.16–18 This often results in some services subsidising
others, with their increased charges generally unrelated to
their value.15 Furthermore, baseline charges are often set
using historical prices calculated before the costs of a
service could be calculated accurately.18 As a result,
charges do not reﬂect costs for individual services, and sig-
niﬁcant variation in distribution of charges for those ser-
vices ensues as different hospitals choose to set their
chargemasters using unique formulas and strategies. The
variation we ﬁnd in charges for common blood tests,
therefore, demonstrates that even for essentially identical
line-item procedures, there appears to be no clear or pre-
dictable method for setting charges.
Limitations
This study evaluated the charges for blood tests, rather
than the negotiated prices paid by most insurers.
Although charges have evoked signiﬁcant controversy in
the popular press,19 20 they are currently billed directly to
the 48.6 million uninsured21 as well as privately insured
patients seeking care out of network. In addition, charges
still have a major impact on healthcare pricing for all
Americans. They often serve as the starting point in fees
for service reimbursement negotiations with many third
party payers,15 22 as a baseline in cost-to-charge ratio ana-
lysis for Diagnosis-related group weighing and outlier
payment reimbursement by Medicare,23–25 and as the
benchmark that most hospitals use to calculate uncompen-
sated care, which affects their tax-exempt non-proﬁt
status.26 Further, as most direct price information is
unavailable to the public, charges represent one avenue to
evaluate the institutional inﬂuences on healthcare price
beyond a patient’s control. Therefore, we believe charges
are worth studying and provide insight on the price vari-
ation and opacity seen in healthcare.
Second, a number of hospitals did not report charges
for each blood test to OSHPD. As there are no incentives
or penalties surrounding the charges reported to OSHPD,
we have no reason to believe that the charges differed sig-
niﬁcantly between reporting and non-reporting hospitals.
However, there is the possibility of bias if the charges sys-
tematically differed between reporters and non-reporters,
which could affect our regression results.
In addition, the analysis only applies to California,
which is a large and diverse state but does not represent
the entire US population. Therefore, the results of this
study cannot be generalised to the national level, but
can provide a good case study of charge variation.
Finally, the charge data is self-reported to OSHPD by
California hospitals. Therefore, the data is only as accurate
as the hospitals reporting. However, we suspect any error
rates are low given that chargemasters are public records,
and any misreporting would probably understate the
charges and likely decrease the variation we documented.
CONCLUSIONS
Charges for 10 common blood tests performed at
California hospitals vary widely across hospitals, with
charges for a lipid panel, for example, ranging from US
$10 to US$10 169. Though hospital ownership and
teaching status were correlated with charges for many
blood tests, few other hospital or market-level predictors
signiﬁcantly predicted blood test charges. At most our
models predicted 21% of the variation in charges for
these identical services. These ﬁndings highlight the
lack of predictability facing Americans paying full
charges for healthcare, limiting their ability to act as
rational consumers.
Acknowledgements The authors thank Joy Lin, BS, for her technical
assistance.
Contributors RYH conceived, designed, supervised and also funded the
study, and interpreted the data analysis. RYH and YAA revised the manuscript
for intellectually important content and approved the final manuscript. YAA
designed the study and ran the data analysis. JPN assisted with the data
analysis, interpreted the data, wrote the first draft of the manuscript, revised
and approved the final version of the manuscript.
6 Hsia RY, et al. BMJ Open 2014;4:e005482. doi:10.1136/bmjopen-2014-005482
Open Access
 group.bmj.com on August 25, 2014 - Published by bmjopen.bmj.comDownloaded from 
Funding UCSF Center for Healthcare Value.
Competing interests This work was supported by the National Center for
Advancing Translational Sciences, National Institutes of Health, through
UCSF-CTSI Grant Number KL2 TR000143 (RYH), the Robert Wood Johnson
Foundation Physician Faculty Scholars Program (RYH), and a UCSF Center for
Healthcare Value grant.
Provenance and peer review Not commissioned; externally peer reviewed.
Data sharing statement The data used in this study are publicly available through
the California Office of Statewide Health Planning and Development (OSHPD). To
request the data, call (916) 326-3802 or e-mail hircweb@oshpd.ca.gov.
Open Access This is an Open Access article distributed in accordance with
the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license,
which permits others to distribute, remix, adapt, build upon this work non-
commercially, and license their derivative works on different terms, provided
the original work is properly cited and the use is non-commercial. See: http://
creativecommons.org/licenses/by-nc/4.0/
REFERENCES
1. Emanuel E, Tanden N, Altman S, et al. A systemic approach to
containing health care spending. N Engl J Med 2012;367:949–54.
2. Government Accountability Office (GAO). Meaningful Price
Information Is Difficult for Consumers to Obtain Prior to Receiving
Care. GAO-11-791, 2011.
3. Leavitt M. Transparency in healthcare a priority. The Hill 10 May
2006:1–2.
4. Melnick G, Keeler E. The effects of multi-hospital systems on
hospital prices. J Health Econ 2007;26:400–13.
5. Milliman. Cost efficiency at hospital facilities in California. Milliman
Inc, 2007.
6. Ginsburg PB. Wide variation in hospital and physician payment rates
evidence of provider market power. Center for Studying Health
System Change, 2010.
7. Hsia RY, Kothari AH, Srebotnjak T, et al. Health care as a “market
good”? Appendicitis as a case study. Arch Intern Med
2012;172:818–19.
8. Office of Statewide Health Planning and Development. Annual
Financial Data: General Information About the Hospital
Chargemaster Program. 2012. http://www.oshpd.ca.gov/HID/
Products/Hospitals/Chrgmstr/index.html (accessed 10 Dec 2013).
9. Health Resources and Services Administration. Area health resource
file. US Department of Health and Human Services, 2009. http://arf.
hrsa.gov (accessed 14 Apr 2014).
10. Centers for Medicare and Medicaid Services. Historical impact files.
US Department of Health and Human Services, 2011. http://www.cms.
gov/Medicare/Medicare-Fee-for-Service-Payment/AcuteInpatientPPS/
Historical-Impact-Files-for-FY-1994-through-Present.html (accessed
14 Apr 2014).
11. Gaynor M, Vogt WB. Competition among hospitals. RAND J Econ
2003;34:764–85.
12. Keeler E B, Melnick G, Zwanziger J. The changing effects of
competition on non-profit and for-profit hospital pricing behavior.
J Health Econ 1999;18:69–86.
13. Baye MR, Morgan J, Scholten P. Temporal price dispersion:
evidence from an online consumer electronics market. J Interact
Mark 2004;18:101–15.
14. Melnick GA, Zwanziger J, Bamezai A, et al. The effects of market
structure and bargaining position on hospital prices. J Health Econ
1992;11:217–33.
15. Ginsburg PB, Grossman JM. When the price isn’t right: how
inadvertent payment incentives drive medical care. Health Aff
(Millwood) 2005:W5.
16. Anderson GF. From ‘soak the rich’ to ‘soak the poor’: recent trends
in hospital pricing. Health Aff (Millwood) 2007;
26:780–9.
17. Lagnado L. California hospitals open books, showing huge price
differences. Wall Street Journal 27 December 2004:A1.
18. Dobson AJ, DaVanzo J, Doherty J, et al. A Study of hospital charge
setting practices. Lewin Group, 2005.
19. Brill S. Bitter pill: why medical bills are killing us. TIME Magazine 20
February 2013:16–55.
20. Salam R. Guest post by Oren Cass: what Steven Brill gets wrong on U.
S. Health Care Costs. The National Review Online 28 February 2013.
http://www.nationalreview.com/agenda/341951/guest-post-oren-cass-
what-steven-brill-gets-wrong-us-health-care-costs-reihan-salam
(accessed 17 Dec 2013).
21. DeNavas-Walt C, Proctor B, Smith J. Income, poverty, and health
Insurance coverage in the United States: 2011. Current Population
Reports. Washington DC: US Census Bureau,
2012:1–81.
22. Reinhardt UE. The pricing of U.S. hospital services: chaos behind a
veil of secrecy. Health Aff (Millwood) 2006;25:57–69.
23. Medicare Program; Change in Methodology for Determining
Payment for Extraordinarily High-Cost Cases (Cost Outliers) Under
the Acute Care Hospital Inpatient and Long-Term Care Hospital
Prospective Payment Systems; Final Rule. 68 Federal Register 110.
( June 9, 2003):34494–504.
24. Medicare Program; Changes to the Hospital Inpatient Prospective
Payment Systems and Fiscal Year 2007 Rates; Fiscal Year 2007
Occupational Mix Adjustment to Wage Index; Health Care
Infrastructure Improvement Program; Selection Criteria of Loan
Program for Qualifying Hospitals Engaged in Cancer-Related Health
Care and Forgiveness of Indebtedness; and Exclusion of Vendor
Purchases Made Under the Competitive Acquisition Program (CAP)
for Outpatient Drugs and Biologicals Under Part B for the Purpose of
Calculating the Average Sales Price (ASP); Final Rules & Interim
Final Rule With Comment Period. 71 Federal Register 160. (August
18, 2006):47870–8351.
25. Medicare Program; Proposed Changes to the Hospital Inpatient
Prospective Payment Systems and Fiscal Year 2009 Rates;
Proposed Changes to Disclosure of Physician Ownership in
Hospitals and Physician Self-Referral Rules; Proposed Collection of
Information Regarding Financial Relationships Between Hospitals
and Physicians; Proposed Rule. 73 Federal Register 84. (April 30,
2008):23542–47.
26. Internal Revenue Service. IRS Exempt Organizations (TE/GE)
Hospital Compliance Project Final Report. 2006:98.
Hsia RY, et al. BMJ Open 2014;4:e005482. doi:10.1136/bmjopen-2014-005482 7
Open Access
 group.bmj.com on August 25, 2014 - Published by bmjopen.bmj.comDownloaded from 
Correction
Hsia RY, Akosa Antwi Y, Nath JP. Variation in charges for 10 common blood tests in California
hospitals: a cross-sectional analysis. BMJ Open 2014;4:e005482. During the prooﬁng process of
this paper the last author ‘Julia B Nath’ was mistakenly changed to ‘Julia P Nath’. The corrrect
author name is ‘Julia B Nath’ and should be cited as ‘Nath JB’.
BMJ Open 2014;4:e005482corr1. doi:10.1136/bmjopen-2014-005482corr1
BMJ Open 2014;4:e005482corr1. doi:10.1136/bmjopen-2014-005482corr1 1
Open Access Miscellaneous
doi: 10.1136/bmjopen-2014-005482
 2014 4: BMJ Open
 
Renee Y Hsia, Yaa Akosa Antwi and Julia P Nath
 
cross-sectional analysis
tests in California hospitals: a 
Variation in charges for 10 common blood
 http://bmjopen.bmj.com/content/4/8/e005482.full.html
Updated information and services can be found at: 
These include:
Data Supplement
 http://bmjopen.bmj.com/content/suppl/2014/07/31/bmjopen-2014-005482.DC1.html
"Supplementary Data"
References
 http://bmjopen.bmj.com/content/4/8/e005482.full.html#ref-list-1
This article cites 9 articles, 2 of which can be accessed free at:
Open Access
non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
terms, provided the original work is properly cited and the use is
work non-commercially, and license their derivative works on different 
license, which permits others to distribute, remix, adapt, build upon this
Creative Commons Attribution Non Commercial (CC BY-NC 4.0) 
This is an Open Access article distributed in accordance with the
service
Email alerting
the box at the top right corner of the online article.
Receive free email alerts when new articles cite this article. Sign up in
Collections
Topic
 (460 articles)Health services research   
 (227 articles)Health policy   
 
Articles on similar topics can be found in the following collections
Notes
 http://group.bmj.com/group/rights-licensing/permissions
To request permissions go to:
 http://journals.bmj.com/cgi/reprintform
To order reprints go to:
 http://group.bmj.com/subscribe/
To subscribe to BMJ go to:
 group.bmj.com on August 25, 2014 - Published by bmjopen.bmj.comDownloaded from 
